Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia
Elaine Coustan‐Smith(St. Jude Children's Research Hospital), Dario Campana(National University of Singapore), Jeffrey E. Rubnitz(St. Jude Children's Research Hospital), Raul C. Ribeiro(St. Jude Children's Research Hospital), José Sancho(St. Jude Children's Research Hospital), Frederick G. Behm(St. Jude Children's Research Hospital), John T. Sandlund(St. Jude Children's Research Hospital), James M. Boyett(University of Illinois Chicago), Gaston K. Rivera(St. Jude Children's Research Hospital), Susana C. Raimondi(St. Jude Children's Research Hospital), Michael L. Hancock(St. Jude Children's Research Hospital), Ching‐Hon Pui(St. Jude Children's Research Hospital)
Cited by 475
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Treatment of Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2006|2k